Biomarker ID | 1443 |
PMID | 24909936 |
Year | 2014 |
Biomarker | MUC1 + p53+ AZGP1 |
Biomarker Basis | Expression Based |
Biomolecule | Protein |
Source | Tissue |
Subjects | Humans |
Regulation | Increased with Increased mortality |
Odds Ratio/Hazard Ratio/Relative Risk | Mortality Rate Ratios: MRR: [MUC1: 2.10 (95% CI: 0.94, 4.69)]; p53: [2.76 (95% CI: 1.23- 6.20)]; AZGP1: [0.47 (95% CI: 0.20-1.08)]; |
Effect on Pathways | NA |
Experiment | PCa Specific Mortality Vs No Mortality |
Type of Biomarker | Prognostic |
Cohort | Subjects were identified from three Australian epidemiological studies. Men who had died of their disease, “cases†(N = 83), were matched to “referents†(N = 232), those who had not died of prostate cancer, using incidence density sampling. |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | NA |
Method Used | Immunohistochemistry |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |